Cargando…

Adverse Effects of Fenofibrate in Mice Deficient in the Protein Quality Control Regulator, CHIP

We previously reported how the loss of CHIP expression (Carboxyl terminus of Hsc70-Interacting Protein) during pressure overload resulted in robust cardiac dysfunction, which was accompanied by a failure to maintain ATP levels in the face of increased energy demand. In this study, we analyzed the ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravi, Saranya, Parry, Traci L., Willis, Monte S., Lockyer, Pamela, Patterson, Cam, Bain, James R., Stevens, Robert D., Ilkayeva, Olga R., Newgard, Christopher B., Schisler, Jonathan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162787/ https://www.ncbi.nlm.nih.gov/pubmed/30111698 http://dx.doi.org/10.3390/jcdd5030043

Ejemplares similares

Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo
por: Abdullah, Muhammad, et al.
Publicado: (2017)

Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge
por: Bain, James R., et al.
Publicado: (2009)

Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins
por: Li, Hui-Hua, et al.
Publicado: (2022)

Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo
por: Jensen, Brian C., et al.
Publicado: (2017)

Exercise-Induced Alterations in Skeletal Muscle, Heart, Liver, and Serum Metabolome Identified by Non-Targeted Metabolomics Analysis
por: Starnes, Joseph W., et al.
Publicado: (2017)

Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of SCAR16
por: Shi, Chang-he, et al.
Publicado: (2018)

Changes in protein function underlie the disease spectrum in patients with CHIP mutations
por: Madrigal, Sabrina C., et al.
Publicado: (2019)

MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet
por: He, Jun, et al.
Publicado: (2015)

Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency
por: Hamilton-Craig, I., et al.
Publicado: (2012)

Emerging evidence of coding mutations in the ubiquitin–proteasome system associated with cerebellar ataxias
por: Ronnebaum, Sarah M, et al.
Publicado: (2014)

OR07-1 Cord Blood Metabolomics: Association with Newborn Anthropometrics and C-Peptide across Ancestries
por: Kadakia, Rachel, et al.
Publicado: (2019)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Cardiac Energy Dependence on Glucose Increases Metabolites Related to Glutathione and Activates Metabolic Genes Controlled by Mechanistic Target of Rapamycin
por: Schisler, Jonathan C., et al.
Publicado: (2015)

Mixture model normalization for non-targeted gas chromatography/mass spectrometry metabolomics data
por: Reisetter, Anna C., et al.
Publicado: (2017)

Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure
por: Parry, Traci L., et al.
Publicado: (2015)

Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet
por: Quintana, Megan T., et al.
Publicado: (2015)

Erratum. Maternal BMI and Glycemia Impact the Fetal Metabolome. Diabetes Care 2017;40:902–910
por: Lowe, William L., et al.
Publicado: (2018)

Maternal BMI and Glycemia Impact the Fetal Metabolome
por: Lowe, William L., et al.
Publicado: (2017)

Metabolic Networks and Metabolites Underlie Associations Between Maternal Glucose During Pregnancy and Newborn Size at Birth
por: Scholtens, Denise M., et al.
Publicado: (2016)

Fibrane the reduced derivative of fenofibrate
por: Kotheimer, Amanda E., et al.
Publicado: (2019)

Mig-6 Plays a Critical Role in the Regulation of Cholesterol Homeostasis and Bile Acid Synthesis
por: Ku, Bon Jeong, et al.
Publicado: (2012)

Targeted Metabolomics Demonstrates Distinct and Overlapping Maternal Metabolites Associated With BMI, Glucose, and Insulin Sensitivity During Pregnancy Across Four Ancestry Groups
por: Jacob, Saya, et al.
Publicado: (2017)

Genetic Networks of Liver Metabolism Revealed by Integration of Metabolic and Transcriptional Profiling
por: Ferrara, Christine T., et al.
Publicado: (2008)

Correction: Genetic Networks of Liver Metabolism Revealed by Integration of Metabolic and Transcriptional Profiling
por: Ferrara, Christine T., et al.
Publicado: (2008)

Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ
por: Mao, Hua, et al.
Publicado: (2017)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
por: Patel, Piyush, et al.
Publicado: (2016)

BMPER Promotes Epithelial-Mesenchymal Transition in the Developing Cardiac Cushions
por: Dyer, Laura, et al.
Publicado: (2015)

Correction: BMPER Promotes Epithelial-Mesenchymal Transition in the Developing Cardiac Cushions
por: Dyer, Laura, et al.
Publicado: (2018)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Detecting responses to treatment with fenofibrate in pedigrees
por: Cherlin, Svetlana, et al.
Publicado: (2018)

Effect of Fenofibrate Medication on Renal Function
por: Kim, Sungjong, et al.
Publicado: (2017)

Fenofibrate-induced renal dysfunction, yes or no?
por: Emami, Fatemeh, et al.
Publicado: (2020)

The role of fenofibrate in the treatment of COVID-19
por: Yasmin, Farah, et al.
Publicado: (2021)

Modeling the Transition From Decompensated to Pathological Hypertrophy
por: Pascual, Florencia, et al.
Publicado: (2018)

Depletion of PHD3 Protects Heart from Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis
por: Xie, Liang, et al.
Publicado: (2015)

Development of a New Positron Emission Tomography Tracer for Targeting Tumor Angiogenesis: Synthesis, Small Animal Imaging, and Radiation Dosimetry
por: Patterson, Cam, et al.
Publicado: (2013)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
Publicado: (2005)

Remodeling of the Acetylproteome by SIRT3 Manipulation Fails to Affect Insulin Secretion or β Cell Metabolism in the Absence of Overnutrition
por: Peterson, Brett S., et al.
Publicado: (2018)

OR14-5 Branched-chain Amino Acid and Tryptophan Metabolism and the Pathogenesis of Youth-Onset Type 2 Diabetes Mellitus (T2D)
por: Armstrong, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p8k5l1bkn4g6s5dn0a082nqur4